ReviewNutrients2026
Nutrition, Circadian Regulation, and the Gut-Melatonin-Visceral Adipose Tissue Axis: An Integrative Narrative Review.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visceral adipose tissue (VAT) dysfunction is a major determinant of obesity-related metabolic disorders, including insulin resistance, metabolic syndrome, cardiovascular disease, and chronic low-grade inflammation. Growing evidence indicates that VAT function is regulated by a complex interplay between nutrition, circadian rhythms, intestinal melatonin secretion, and the gut microbiota rather than by isolated metabolic pathways. The gastrointestinal tract represents an important interface between dietary exposures, microbial activity, immune signaling, and host metabolic regulation. Melatonin is a potential component of this network because it participates in circadian regulation and has been detected in gastrointestinal tissues, while experimental studies suggest that intestinal melatonin signaling may interact with gut microbial and metabolic processes. However, the cellular sources, quantitative contribution, local dynamics, and physiological significance of intestinal melatonin remain incompletely established, particularly in humans. This narrative review integrates current evidence regarding the interactions between nutrition, circadian regulation, intestinal melatonin, gut microbiota, and visceral adipose tissue. Rather than proposing a validated causal pathway, we introduce the Gut-Melatonin-Visceral Adipose Tissue (Gut-Melatonin-VAT) Axis as an integrative, hypothesis-generating conceptual framework that organizes established interactions together with candidate mechanisms requiring further experimental validation. Particular attention is given to the bidirectional relationships among dietary composition, meal timing, microbial rhythmicity, intestinal signaling, immune regulation, and VAT dysfunction. The framework may provide a basis for generating testable hypotheses concerning nutritional, chrononutritional, microbiota-targeted, and melatonin-related interventions, while recognizing that direct human evidence validating the complete pathway is currently lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.